v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Class A Common Stock
Class B Common Stock
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid in Capital
Accumulated Deficit
Accumulated  Other Comprehensive Income
Treasury Stock Amount
Beginning balance (in shares) at Dec. 31, 2023       472,697 393,014        
Beginning balance at Dec. 31, 2023 $ 840,306     $ 46 $ 39 $ 7,149,858 $ (5,933,943) $ 36,488 $ (412,182)
Increase (Decrease) in Stockholders' Equity                  
Exercise of stock options (in shares)       630          
Exercise of stock options 2,857         2,857      
Stock-based compensation 117,702         117,702      
Exercise of warrants (in shares)       1,002          
Exercise of warrants 46,181         46,181      
Restricted stock unit vesting (in shares)       2,520          
Purchase of treasury stock (in shares)       (782)          
Purchase of treasury stock (33,499)               (33,499)
Net income (loss) (142,568)           (142,568)    
Ending balance (in shares) at Mar. 31, 2024       476,067 393,014        
Ending balance at Mar. 31, 2024 830,979     $ 46 $ 39 7,316,598 (6,076,511) 36,488 (445,681)
Beginning balance (in shares) at Dec. 31, 2023       472,697 393,014        
Beginning balance at Dec. 31, 2023 840,306     $ 46 $ 39 7,149,858 (5,933,943) 36,488 (412,182)
Increase (Decrease) in Stockholders' Equity                  
Shares issued for contingent consideration 331,557                
Net income (loss) (78,746)                
Ending balance (in shares) at Jun. 30, 2024       485,426 393,014        
Ending balance at Jun. 30, 2024 1,298,429     $ 47 $ 39 7,744,638 (6,012,689) 36,488 (470,094)
Beginning balance (in shares) at Mar. 31, 2024       476,067 393,014        
Beginning balance at Mar. 31, 2024 830,979     $ 46 $ 39 7,316,598 (6,076,511) 36,488 (445,681)
Increase (Decrease) in Stockholders' Equity                  
Exercise of stock options (in shares)       257          
Exercise of stock options 2,586         2,586      
Stock-based compensation 93,681         93,681      
Exercise of warrants (in shares)       6          
Exercise of warrants 217         217      
Purchase of treasury stock for RSU withholding (in shares)       (631)          
Purchase of treasury stock for RSU withholding (24,413)               (24,413)
Shares issued for contingent consideration (in shares)       7,757          
Shares issued for contingent consideration 331,557     $ 1   331,556      
Restricted stock unit vesting (in shares)       1,970          
Net income (loss) 63,822           63,822    
Ending balance (in shares) at Jun. 30, 2024       485,426 393,014        
Ending balance at Jun. 30, 2024 1,298,429     $ 47 $ 39 7,744,638 (6,012,689) 36,488 (470,094)
Beginning balance (in shares) at Dec. 31, 2024   489,071 393,014 489,071 393,014        
Beginning balance at Dec. 31, 2024 1,010,626     $ 48 $ 39 7,978,425 (6,441,228) 36,488 (563,146)
Increase (Decrease) in Stockholders' Equity                  
Exercise of stock options (in shares)       1,268          
Exercise of stock options 3,396         3,396      
Stock-based compensation 100,380         100,380      
Exercise of warrants (in shares)       182          
Exercise of warrants 8,973         8,973      
Purchase of treasury stock for RSU withholding (in shares)       (1,519)          
Purchase of treasury stock for RSU withholding (74,318)               (74,318)
Restricted stock unit vesting (in shares)       11,001          
Purchase of treasury stock (in shares)       (3,664)          
Purchase of treasury stock (142,278)               (142,278)
Net income (loss) (33,864)           (33,864)    
Ending balance (in shares) at Mar. 31, 2025       496,339 393,014        
Ending balance at Mar. 31, 2025 872,915     $ 48 $ 39 8,091,174 (6,475,092) 36,488 (779,742)
Beginning balance (in shares) at Dec. 31, 2024   489,071 393,014 489,071 393,014        
Beginning balance at Dec. 31, 2024 $ 1,010,626     $ 48 $ 39 7,978,425 (6,441,228) 36,488 (563,146)
Increase (Decrease) in Stockholders' Equity                  
Exercise of stock options (in shares) 2,004                
Shares issued for contingent consideration $ 4,962                
Purchase of treasury stock (in shares) (6,500)                
Purchase of treasury stock $ (242,700)                
Net income (loss) 124,072                
Ending balance (in shares) at Jun. 30, 2025   496,051 393,014 496,051 393,014        
Ending balance at Jun. 30, 2025 1,009,628     $ 48 $ 39 8,197,948 (6,317,156) 36,488 (907,739)
Beginning balance (in shares) at Mar. 31, 2025       496,339 393,014        
Beginning balance at Mar. 31, 2025 872,915     $ 48 $ 39 8,091,174 (6,475,092) 36,488 (779,742)
Increase (Decrease) in Stockholders' Equity                  
Exercise of stock options (in shares)       736          
Exercise of stock options 2,908         2,908      
Stock-based compensation 89,792         89,792      
Exercise of warrants (in shares)       74          
Exercise of warrants 2,212         2,212      
Purchase of treasury stock for RSU withholding (in shares)       (780)          
Purchase of treasury stock for RSU withholding (27,534)               (27,534)
Shares issued under ESPP (in shares)       218          
Shares issued under Employee Stock Purchase Plan 6,900         6,900      
Shares issued for contingent consideration (in shares)       110          
Shares issued for contingent consideration $ 4,962         4,962      
Restricted stock unit vesting (in shares)       2,226          
Purchase of treasury stock (in shares) (2,900)     (2,872)          
Purchase of treasury stock $ (100,463)               (100,463)
Net income (loss) 157,936           157,936    
Ending balance (in shares) at Jun. 30, 2025   496,051 393,014 496,051 393,014        
Ending balance at Jun. 30, 2025 $ 1,009,628     $ 48 $ 39 $ 8,197,948 $ (6,317,156) $ 36,488 $ (907,739)